Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/19/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Jag H. Khalsa

Wrong Dr. Jag H. Khalsa?

Chief, Medical Consequences Branc...

Phone: (301) ***-****  
Email: j***@***.gov
National Institutes of Health
31 Center Dr. MSC 2062 Building 31, Room B1-W30
Bethesda , Maryland 20892
United States

Company Description: About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S....   more
Background

Employment History

  • Chief, Medical Consequences Branch
    NIDA
  • Member, Center On AIDS
    NIDA
  • Chief
    National Institute
  • Chief of the Medical Consequences Branch
    National Institute
  • Chief, Medical Consequences Branch, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
    National Institute on Drug Abuse, NIH
  • Chief, Medical Consequences of Drug Abuse and Infections
    US National Institutes of Health
  • Clinical Evaluator
    Food and Drug Administration
  • Director of Bureau of Foods
    Food and Drug Administration
  • Co-chair
    Center on AIDS
  • Pharmacologist and Health Scientist Administrator
    Center on AIDS

Education

  • PhD , neuro-psycho-pharmacology
  • Master's degree , herbal pharmacology
  • MS
  • Ph.D.
28 Total References
Web References
Now, NIDA-supported researchers at McLean ...
www.fairkids.com [cached]
Now, NIDA-supported researchers at McLean Hospital in Belmont, Massachusetts, and Columbia University in New York City have shown that individuals who regularly smoke marijuana experience withdrawal symptoms after they stop smoking the drug."These studies suggest that in real-world situations abstinence from daily marijuana smoking creates withdrawal symptoms similar to those of other drugs of abuse," says Dr. Jag Khalsa of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse.
Editorial Board Members | USG
blumsrewarddeficiencysyndrome.com [cached]
Dr. Jag Khalsa, with about 50 years of experience in drug research, serves as the Chief of the Medical Consequences Branch, National Institute on Drug Abuse, NIH, DHHS; is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He also serves on numerous Federal and NIH level committees including the HHS Viral Hepatitis Implementation Group (VHIG), National Commission on Digestive Diseases and its two sub-committees (Liver Research, Diabetes Research), Federal Task Force on TB, NIH Steering Committee on Centers for AIDS Research, and Human Microbiome Workgroup. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from SNIP and International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), the President of the American Society of Addiction Medicine (ASAM), and a Certificate of Appreciation from the Office of Assistant Secretary for Health (Drs. Howard Koh and Ron Valdiserri), DHHS. He has a PhD in neuro-psycho-pharmacology, a Master's degree in herbal pharmacology, post-doctoral training in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. Jag Khalsa, MS, PhD
Dr. Jag Khalsa is the Chief ...
www.isdakovalam.com, 25 Feb 2008 [cached]
Dr. Jag Khalsa is the Chief of the Medical Consequences (MC) Branch, within the Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, a part of the U.S. National Institutes of Health.He is trained in neuropharmacology, toxicology and epidemiology.The MC Branch is responsible for supporting domestic and international research on health and medical consequences of drug abuse and co-occurring infections including HIV, hepatitis, STDs, TB, and other opportunistic infections.The research programs include diseases/disorders of the heart, liver, and immune system; metabolic, endocrine and gastrointestinal disorders; pharmacokinetic/pharmacodynamic drug-drug interactions among drugs of abuse, and pharmacotherapeutic agents used in the treatment of infections (HIV, HCV) and drug addiction; and misuse of prescription drugs.He has several publications in the field of pharmacology, toxicology, epidemiology and medicine.He has received numerous awards of merit including ones from the FDA Commissioner, Director of FDA's Bureau of Foods, NIDA Director's Awards of Merit (3 in a row), NIH Director's Award, and a citation from the United States Congress.
NIDA - What's New - Past Meetings - 3rd International Workshop on Clinical Pharmacology of HIV Therapy
nida.demo.iqsolutions.com [cached]
Based on these facts, Dr. Charles Flexner of Johns Hopkins School of Medicine and Jag Khalsa, Ph.D. of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA), in collaboration with Dr. Frank Vocci of the Division of Treatment and Research Development (DTRD) and Dr. Steve Gust of the Office of the Director (OD, NIDA), organized a mini-symposium at the 3rd International Workshop on Clinical Pharmacology of HIV Therapy, Washington, DC, April 13, 2002, where experts in HIV pharmacology, substance abuse, pharmacogenomics, and pharmacokinetic modeling presented current data on the subject of drug-drug interactions.
...
Co-chair: Jag H. Khalsa, Ph.D., Center on AIDS & Other Medical Consequences of Drug Abuse (CAMCODA), National Institute on Drug Abuse, NIH, Bethesda, Maryland.
Other People with the name "Khalsa":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304